THE COMMITMENT TO RESEARCH
Since 1996, Erchonia, the manufacturer of Lunula, has been committed to fully elucidating the medical utility of low level laser therapy through rigorous clinical studies. For almost 2 decades, Erchonia has studied the clinical utility of low level laser devices for the treatment of numerous medical ailments. Their recent device, Lunula, looks to revolutionize the way the medical community treats onychomycosis.
Lunula has been markedly studied – from the early in-vitro analysis to the extensive in-vivo studies – and its clinical utility to treat painful and unsightly toenail infections has been substantiated. The unique dual-diode approach of Lunula effectively targets the causative infectious agent while fortifying the body’s natural defense mechanisms. This multifaceted approach is the first of its kind, providing patients with a truly effective, yet safe, treatment for onychomycosis.
As you will quickly learn, Lunula is supported by an unwavering clinical foundation of both histological and clinical evidence that upholds the viability of this approach and ensures an effective treatment for your patients suffering with onychomycosis. In fact, Lunula is so unique, Erchonia has filed multiple method and device patents specific to Lunula.
HOW THE COMPETITION STACKS UP TO LUNULA
BEFORE & AFTER
[su_row] [su_column size=”1/3″]
Lunula Laser on ITV1[su_youtube_advanced url=”https://www.youtube.com/watch?v=UHHQB01yUu4″ controls=”yes” showinfo=”yes” rel=”no”] [/su_column] [su_column size=”1/3″]
Robert Sullivan, Clinical Director, Midleton Foot Clinic Presentation on Lunula Laser[su_youtube_advanced url=”https://www.youtube.com/watch?v=14rCxlbC_pM” controls=”yes” showinfo=”yes” rel=”no”] [/su_column] [su_column size=”1/3″]
Lunula Science Webinar[su_youtube_advanced url=”https://www.youtube.com/watch?v=No1i3SIYDG4″ controls=”yes” showinfo=”yes” rel=”no”] [/su_column] [/su_row]